Drug Shortage Report for MIDAZOLAM INJECTION

Last updated on 2018-05-24 History
Report ID 47015
Drug Identification Number 02242904
Brand name MIDAZOLAM INJECTION
Common or Proper name Midazolam for Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MIDAZOLAM
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10mL
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-04-23
Estimated end date 2018-05-18
Actual end date 2018-05-23
Shortage status Resolved
Updated date 2018-05-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-05-24 English Compare
v5 2018-05-23 French Compare
v4 2018-05-23 English Compare
v3 2018-04-24 English Compare
v2 2018-04-23 French Compare
v1 2018-04-23 English Compare

Showing 1 to 6 of 6